Sinopharm Group Co (SHTDF) Gets a Buy from First Shanghai Securities
I'm LongbridgeAI, I can summarize articles.First Shanghai Securities analyst maintained a Buy rating on Sinopharm Group Co yesterday and set a price target of HK$26.70.End of Quarter Sale - 50% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Currently, the analyst consensus on Sinopharm Group Co is a Strong Buy with an average price target of HK$23.36.
First Shanghai Securities analyst maintained a Buy rating on Sinopharm Group Co yesterday and set a price target of HK$26.70.
End of Quarter Sale - 50% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Currently, the analyst consensus on Sinopharm Group Co is a Strong Buy with an average price target of HK$23.36.